Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Genzyme VP, Biotech Spokeswoman Raines Killed In D.C. Plane Crash

Executive Summary

Genzyme VP-Government Relations Lisa Raines was among the people killed on American Airlines flight 77 when it crashed into the Pentagon in Washington, D.C. Sept. 11.

You may also be interested in...



Patent Incentive For Bioterrorism Research Offered In Lieberman Bill

Pharmaceuticals approved for use as anti-bioterrorism agents would be eligible for full patent term restoration under legislation introduced by Sen. Joe Lieberman (D-Conn.) on Dec. 4

BIO, Genzyme Working With Sen. Hatch On Orphan Drug Tax Credit Refinement

Legislation that would allow drug companies to begin receiving orphan drug tax credits earlier is being developed by Sen. Hatch (R-Utah) with input from the Biotechnology Industry Organization and Genzyme.

Amgen Working With Sen. Kennedy On Medicare Rx Benefit Bill

Amgen is working with the ranking Democrat on the Senate Health Committee, Sen. Kennedy (D-Mass.), to develop a Medicare prescription drug benefit bill.

UsernamePublicRestriction

Register

LL005491

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel